奇胺作为癌症免疫治疗中的VISTA/PSGL-1阻断剂
Xiaoshuang Niu1, Wenshan Zhao2, Xiuman Zhou1
1School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-Sen University, Shenzhen, 518107, China.
Cancer immunology, immunotherapy : CII
|February 11, 2025
概括
奇胺有效地阻断VISTA/PSGL-1免疫检查点,增强CD8+T细胞功能. 这种药物重新利用的发现提供了一种有前途的新策略,通过抑制瘤生长来治疗癌症免疫疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 目前使用PD-1/PD-L1阻断的癌症免疫治疗具有有限的响应率.
- 作为一种免疫检查点,VISTA通过与酸性瘤微环境中的PSGL-1相互作用来抑制CD8+T细胞功能.
- 药物再利用是开发新疗法的一种有效和安全的方法.
研究的目的:
- 通过药物重新定位来识别新的VISTA/PSGL-1抑制剂.
- 评估基达米德作为癌症免疫治疗中的VISTA/PSGL-1抑制剂的疗效.
主要方法:
- 选市场药物库,以确定与VISTA结合的化合物.
- 评估基达胺与VISTA的结合亲和力 (KD).
- 在酸性条件下评估VISTA/PSGL-1相互作用的阻断.
- 在小鼠CT26模型中测试CD8+T细胞功能的增强和瘤生长抑制.
主要成果:
- 奇达胺对VISTA表现出强烈的结合亲和力 (KD = 5nM).
- 在酸性条件下,奇胺成功地阻断了VISTA/PSGL-1相互作用.
- 在体内观察到显著增强CD8+T细胞功能和抑制瘤生长.
- 这项研究是第一个确定奇达米德作为VISTA/PSGL-1阻断剂的研究.
结论:
- 奇达胺是一种强大的VISTA/PSGL-1抑制剂,在癌症免疫治疗中具有治疗潜力.
- 奇达米德的药物重定向提供了一种新且有效的策略,以克服当前免疫检查点抑制剂的局限性.
- 用奇达胺针对VISTA/PSGL-1增强了抗瘤免疫力,需要进一步的临床研究.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
215
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
215
Tumor Immunotherapy
464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464
Direct-Acting Cholinergic Agonists: Therapeutic Uses
673
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
673
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


